Traders Buy Shares of UnitedHealth Group (UNH) on Weakness on Insider Selling

Investors bought shares of UnitedHealth Group (NYSE:UNH) on weakness during trading on Monday following insider selling activity. $301.01 million flowed into the stock on the tick-up and $91.74 million flowed out of the stock on the tick-down, for a money net flow of $209.27 million into the stock. Of all stocks tracked, UnitedHealth Group had the 5th highest net in-flow for the day. UnitedHealth Group traded down ($0.72) for the day and closed at $234.34Specifically, Director Kenneth Irwin Shine sold 202 shares of the stock in a transaction that occurred on Thursday, April 19th. The shares were sold at an average price of $237.42, for a total transaction of $47,958.84. Following the completion of the sale, the director now directly owns 28,948 shares of the company’s stock, valued at $6,872,834.16. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Larry C. Renfro sold 22,184 shares of the stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the sale, the insider now directly owns 173,229 shares of the company’s stock, valued at $39,659,047.26. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 77,019 shares of company stock valued at $17,879,133. Company insiders own 0.89% of the company’s stock.

UNH has been the topic of a number of recent analyst reports. Goldman Sachs initiated coverage on shares of UnitedHealth Group in a report on Wednesday, January 3rd. They set a “buy” rating and a $269.00 price target on the stock. Credit Suisse Group restated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 27th. Cantor Fitzgerald restated a “buy” rating and set a $235.00 price target on shares of UnitedHealth Group in a report on Monday, December 25th. Deutsche Bank boosted their price target on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Finally, Citigroup boosted their price target on shares of UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Three analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $251.13.

How to Become a New Pot Stock Millionaire

The company has a current ratio of 0.71, a quick ratio of 0.73 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $227,458.84, a PE ratio of 23.27, a price-to-earnings-growth ratio of 1.36 and a beta of 0.77.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.91 by $0.13. The business had revenue of $55.19 billion during the quarter, compared to the consensus estimate of $54.90 billion. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. UnitedHealth Group’s quarterly revenue was up 13.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.37 EPS. equities analysts predict that UnitedHealth Group will post 12.61 EPS for the current year.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Exane Derivatives boosted its stake in shares of UnitedHealth Group by 15,333.3% in the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after purchasing an additional 460 shares during the last quarter. Aevitas Wealth Management Inc. bought a new position in shares of UnitedHealth Group in the 4th quarter valued at about $102,000. Pathstone Family Office LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $129,000. Trustcore Financial Services LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $133,000. Finally, Intellectus Partners LLC boosted its stake in UnitedHealth Group by 18.2% during the 2nd quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock worth $152,000 after acquiring an additional 126 shares during the last quarter. 86.73% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Traders Buy Shares of UnitedHealth Group (UNH) on Weakness on Insider Selling” was first posted by Week Herald and is owned by of Week Herald. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://weekherald.com/2018/04/23/traders-buy-shares-of-unitedhealth-group-unh-on-weakness-on-insider-selling.html.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply